Millennium Health Signals Report™
The COVID-19 Connection:
Tracking 2020 Trends in Drug Use

Shifts in Illicit Drug Use Heighten the COVID-19 Health Crisis

This report includes an analysis of our proprietary database of definitive urine drug test results for non-prescribed fentanyl, methamphetamine, heroin, and cocaine, comparing pre-COVID-19 (March 13, 2019 – December 31, 2019) and COVID-19 (March 13, 2020 – December 31, 2020) time periods.

Section 1 findings reveal that during COVID-19:

Nationally, fentanyl and methamphetamine, increased 78% and 29%, respectively
Fentanyl increased significantly in all U.S. census divisions, led by increases in the Pacific division. Four Pacific states (Washington, Oregon, Alaska, and California) more than doubled their fentanyl positivity
Methamphetamine increases were led by the New England and Mid Atlantic divisions
After initially increasing, cocaine and heroin appear to have fallen below March 13, 2020 levels

Other sections in the report include:

The Collapse of Carfentanil
An Evaluation of Pain Medication Misuse in the Midst of the Pandemic
Methadone Maintenance: Unexpected Findings Raise Risks

First Name *

Last Name *

I am a... *

Industry

Company *

Title *

Email *

Phone *

Zip Code *

Comments

By clicking the button above, you are agreeing to receive email communications from Millennium Health and we’ll send you product updates, company news, and marketing content. By doing so, you also agree to our Terms of Service and Privacy Policy.

Millennium Health Signals Report™ The COVID-19 Connection: Tracking 2020 Trends in Drug Use

Millennium Health Signals Report™
The COVID-19 Connection:
Tracking 2020 Trends in Drug Use